Is nitric oxide involved in the anticonvulsant action of antiepileptic drugs?

Polish Journal of Pharmacology

Volumn 55, Issue 4, 2003, Pages 535-542

  Wojtal, Katarzyna ^a   Gniatkowska Nowakowska, Anna ^b   Czuczwar, Stanisław J ^c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Outpatient Clinic of Child Neurology   (Poland)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Nitric oxide; Nitric oxide synthase inhibitors; Seizures

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 7 NITROINDAZOLE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINOOXYACETIC ACID; AMINOPHYLLINE; ANTICONVULSIVE AGENT; ARGININE DERIVATIVE; BICUCULLINE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; DICARBOXYLIC ACID DERIVATIVE; DIZOCILPINE; ENOXACIN; ETHOSUXIMIDE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; PILOCARPINE; QUINOLINIC ACID; SOMAN; UNINDEXED DRUG; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; BINDING AFFINITY; BRAIN ISCHEMIA; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ELECTROSTIMULATION; EPILEPSY; EPILEPTOGENESIS; EXPERIMENTAL MODEL; HYPERBARIC OXYGEN; NONHUMAN; REVIEW;

ANIMALS; ANTICONVULSANTS; ENZYME INHIBITORS; HUMANS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PIPERAZINES; SEIZURES;

EID: 0141613677     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Arnold W.P., Mittal C.K., Katsuki S., Murad F.: Nitric oxide activates guanylate cyclase and increases cGMP levels in various tissue preparations. Proc. Nat. Acad. Sci. USA, 1977, 74, 3203-3206.
2. Babbedge R.C., Bland-Ward P.A., Hart S.L., Moore P.K.: Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles. Brit. J. Pharmacol., 1993, 110, 225-229.
3. Baran L., Siwanowicz J., Przegaliński E.: Effect of nitric oxide synthase inhibitors and molsidomine on the anticonvulsant activity of some antiepileptic drugs. Pol. J. Pharmacol., 1997, 49, 363-368.
4. Becker A., Grecksch G., Schröder H.: N-omega-nitro-L-arginine methyl ester interferes with pentylenete-trazol-induced kindling and has no effect on changes in glutamate binding. Brain Res., 1995, 688, 230-232.
5. Borowicz K.K., Kleinrok Z., Czuczwar S.J.: Influence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic drugs. Eur. J. Pharmacol., 1997, 331, 127-132.
6. Borowicz K.K., Kleinrok Z., Czuczwar S.J.: 7-Nitroindazole differentially affects the anticonvulsant activity of antiepileptic drugs against amygdala-kindled seizures in rats. Epilepsia, 2000, 41, 1112-1118.
7. Borowicz K.K., Łuszczki J., Kleinrok Z., Czuczwar S.J.: 7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J. Neural Transm., 2000, 107, 1117-1126.
8. G-nitroarginine methyl esther, an inhibitor of nitric oxide synthase, upon the anticonvulsive activity of conventional antiepileptic drugs against maximal electroshock in mice. J. Neural Transm., 1998, 105, 1-12.
9. Boveris A., Alvarez S., Navarro A.: The role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radical Biol. Med., 2002, 33, 1186-1193.
10. Böhme G.A., Bon C., Stutzman J.M., Doble A., Blanchard J.C.: Possible involvement of nitric oxide in long-term potentiation. Eur. J. Pharmacol., 1991, 199, 379-381.
11. Bredt D.S., Snyder S.H.: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Nat. Acad. Sci. USA, 1989, 86, 9030-9033.
12. Bredt D.S., Snyder S.H.: Nitric oxide as a neuronal messenger. Trends Pharmacol. Sci., 1991, 12, 125-128.
13. Brüne B., Von Knethen A., Sandau K. B.: Nitric oxide and its role in apoptosis. Eur. J. Pharmacol., 1998, 351, 261-272.
14. Buisson A., Lackhmeche N., Verrecia C., Plotkine M., Bolou R.G.: Nitric oxide: an endogenous anticonvulsant substance. NeuroReport, 1993, 4, 444-446.
15. Chavko M., Xing G., Keyser D.O.: Increased sensitivity to seizures in repeated exposures to hyperbaric oxygen: role of NOS activation. Brain Res., 2001, 900, 227-233.
16. G-Nitro-L-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazol. Eur. J. Pharmacol., 1999, 366, 137-142.
17. De Sarro G.B., Donato di Paola E., De Sarro A., Vidal M.J.: Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundam. Clin. Pharmacol., 1991, 5, 503-511.
18. De Sarro G.B., Donato di Paola E., De Sarro A., Vidal M.J.: L-Arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur. J. Pharmacol., 1993, 230, 151-158.
19. De Sarro G., Gareri P., Falconi U., De Sarro A.: 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur. J. Pharmacol., 2000, 394, 275-288.
20. G-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions. Eur. J. Pharmacol., 1996, 29939-16.
21. Garthwaite J.: Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci., 1991, 14, 60-67.
22. Garthwaite J.: Nitric oxide signalling in the nervous system. Semin. Neurosci., 1993, 5, 171-180.
23. Garthwaite J., Charles S.L., Chess-Williams R.: Endothelium-derived relaxing factor release on activation of NMDA receptor suggests a role as intercellular messenger in the brain. Nature, 1988, 336, 385-388.
24. Haberny K.A., Pou S., Eccles C.U.: Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci. Lett., 1992, 146, 187-190.
25. Haefely W.E.: GABA and the anticonvulsant action of benzodiazepines and barbiturates. Brain Res. Bull., 1980, 5, Suppl. 2. 873-877.
26. Hoffman M.A.: A new role for gases: neurotransmission [news]. Science, 1991, 252, 1788.
27. Ito M., Karachot L.: Messengers mediating long-term desensitization in cerebellar Purkinje cells. Neuro-Report, 1991, 1, 129-132.
28. Kirkby R.D., Carroll D.M., Grossman A.B., Subramaniam S.: Factors determining proconvulsant and anti-convulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy Res., 1996, 24, 91-100.
29. Lallement G., Shih T.M., Pernot-Marino I., Baubichon D., Foquin A., McDonough J.H.: The role of nitric oxide in soman-induced seizures, neuropathology, and lethality. Pharmacol. Biochem. Behav., 1996, 54, 731-737.
30. Leite J.P., Chimelli L., Terra-Bustamante VC., Costa E.T., Assirati J.A., Nucci G., Martins A.R.: Loss and sprouting of nitric oxide synthase neurons in the human epileptic hippocampus. Epilepsia, 2002, 43, Suppl. 5, 235-242.
31. Masukawa T., Nakanishi K., Natsuki R.: Role of nitric oxide in the convulsions following the coadministration of enoxacin with fenbufen in mice. Jpn. J. Pharmacol., 1998, 76, 425-429.
32. Moncada S., Palmer R.M.J., Higgs E.A.: Nitric oxide: physiology, patophysiology and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
33. Mülsch A., Busse R., Mordvintcev P.I., Vanin A.F., Nielsen E.O., Scheel-Krüger J., Olesen S.P.: Nitric oxide promotes seizure activity in kainate-treated rats. NeuroReport, 1994, 21, 2325-2328.
34. O'Dell T.J., Hawkins R.D., Kandel E.R., Arancio O.: Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Nat. Acad. Sci. USA, 1991, 88, 11285-11289.
35. Osonoe K., Mori N., Suzuki K., Osonoe M.: Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res., 1994, 663, 338-340.
36. Penix L.P., Davis W., Subramaniam S.: Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res., 1994, 18, 177-184.
37. Przegaliński E., Baran L., Siwanowicz J.: The role of nitric oxide in kainate-induced seizures in mice. Neurosci. Lett., 1994, 170, 74-76.
38. Przegaliński E., Baran L., Siwanowicz J.: The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci. Lett., 1996, 217, 145-148.
39. Raevskii K.S., Bashkatova V.G., Vanin A.F.: The role of nitric oxide in brain glutaminergic pathology. Vestn. Ross. Akad. Med. Nauk., 2000, 4, 11-15.
40. Rondouin G., Bockaert J., Lerner-Natoli M.: L-Nitro-arginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. NeuroReport, 1993, 4, 1187-1190.
41. Rondouin G., Lerner-Natoli M., Manzoni O., Lafon-Cazal M., Bockaert J.: A nitric oxide (NO) synthase inhibitor accelerates amygdala kindling. NeuroReport, 1992, 3, 805-808.
42. Salerno L., Sorrenti V., Di Giacomo C., Romeo G., Siracusa M.A.: Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr. Pharm. Des., 2002, 8, 177-200.
43. Shanley T.P., Zhao B., Macariola D.R., Denenberg A., Salzman A.L., Ward P.A.: Role of nitric oxide in acute lung inflammation: lessons learned from the inducible nitric oxide synthase knockout mouse. Crit. Care Med., 2002, 30, 1960-1968.
44. Shibuki K., Okada D.: Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature, 1991, 349, 326-328.
45. Shukla A., Dikshit M., Srimal R.C.: Nitric oxide modulates blood-brain barrier permeability during infections with an activated bacterium. NeuroReport, 1995, 6, 1629-1632.
46. Shuman E.M., Madison D.V.: A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science, 1991, 254, 1503-1506.
47. Smith S.E., Man C.M., Yip P.K., Tang E., Chapman A.G., Meldrum B.S.: Anticonvulsant effects of 7-nitro-indazole in rodents with reflex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or citrulline formation. Brit. J. Pharmacol., 1996, 119, 165-173.
48. Snyder S.: Nitric oxide: first in a new class of neurotransmitters? Science, 1992, 257, 494-496.
49. Starr M.S., Starr B.S.: Paradoxal facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol. Biochem. Behav., 1993, 45, 321-325.
50. Starr M.S., Starr B.S.: Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide? Eur. J. Pharmacol., 1995, 272, 211-217.
51. Theard M.A., Baughman V.L., Wang Q., Pellegrino D.A., Albrecht R.F.: The role of nitric oxide in modulating brain activity and blood flow during seizure. NeuroReport, 1995, 6, 921-924.
52. Trojnar M.K., Małek R., Chrościńska M., Nowak S., Błaszczyk B., Czuczwar S.J.: Neuroprotective effects of antiepileptic drugs. Pol. J. Pharmacol., 2002, 54, 557-566.
53. G-Nitro-L-arginine differentially affects glutamate- or kainate-induced seizures. NeuroReport, 1996, 7, 1605-1608.
54. Tutka P., Olszewski K., Woźniak M., Kleinrok Z., Czuczwar S.J., Wielosz M.: Molsidomine potentiates the protective activity of GYKI 52466, a non-NMDA antagonist, MK-801, a non-competitive NMDA antagonist, and riluzole against electroconvulsions in mice. Eur. Neuropsychopharmacol., 2002, 12, 321-326.
55. G-nitro-L-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice. J. Neural Transm., 1996, 103, 1145-1152.
56. Van Leeuven R., De Vries R., Dzoljic M.R.: 7-Nitro-indazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures. Eur. J. Pharmacol., 1995, 287, 211-213.
57. Wang Q., Theard M.A., Pelligrino D.A., Baughman V.L., Hoffman W.E., Albrecht R.F., Cwik M., Paulson O.B., Lassen N.A.: Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats. Brain Res., 1994, 658, 192-196.
58. Willis S., Allescher H.-D., Weigert N., Schusdziarra V., Schumpelick V.: Influence of the L-arginine-nitric oxide pathway on vasoactive intestinal polypeptide release and motility in the rat stomach in vitro. Eur. J. Pharmacol., 1996, 315, 59-64.
59. Zagvazdin Y., Sancesario G., Wang Y.X., Share L., Fitzgerald M.E.C., Reiner A.: Evidence from its cardiovascular effects that 7-nitroindazole may inhibit endothelial nitric oxide synthase in vivo. Eur. J. Pharmacol., 1996, 303, 61-69.